Latest Whitepapers

This whitepaper explores the latest reagents and software available to enhance tumor exome profiling for the generation of accurate, actionable clinical insights.

The rapid and accurate identification of microbial contaminants is crucial for quality control in pharmaceutical processes and products. However, until recently, testing labs have relied on time-consuming phenotypic approaches to ensure that safety standards are met.

Developing mRNA-based therapeutics is complex work, requiring highly skilled scientists, high-tech microfluidics platforms and sophisticated analytical equipment, and of course the mRNA itself.

This whitepaper highlights how vendor-qualified, automated library preparation methods can accelerate a variety of NGS workflows.

This whitepaper highlights specific case studies that reveal how researchers are applying nanopore technology to a variety of sequencing techniques, including whole genome, targeted, RNA sequencing and single-cell analysis.

Innovation is key for any biopharmaceutical and biotechnology company. Whilst the demand for infectious disease prevention continues to grow, so does the pressure on these companies to deliver innovative solutions.

Recent technological advancements have made single-cell sequencing an increasingly powerful tool for understanding biology and cellular function, disease diagnosis, therapy response prediction, and treatment selection.

Only a small amount of cell-free DNA (cfDNA) can be found in circulation, therefore efficient and highly sensitive technologies such as next-generation sequencing (NGS) are typically being used to detect this biomarker.

Biofuels have garnered increased attention due to the economic and environmental concerns associated with petroleum-based fuel.

CRISPR/Cas9 has revolutionized the field of genome editing by increasing the efficiency, multiplex capability and ease of use like never before.